Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

Esteban D Braggio, Ahmet Dogan, Jonathan J. Keats, Wee J. Chng, Gaofeng Huang, Julie M. Matthews, Matthew J. Maurer, Mark E. Law, David S. Bosler, Michael Barrett, Izidore S. Lossos, Thomas Elmer Witzig, Rafael Fonseca

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Lymphoplasmacytic lymphomas and marginal zone lymphomas of nodal, extra-nodal and splenic types account for 10% of non-Hodgkin lymphomas. They are similar at the cell differentiation level, sometimes making difficult to distinguish them from other indolent non-Hodgkin lymphomas. To better characterize their genetic basis, we performed array-based comparative genomic hybridization in 101 marginal zone lymphomas (46 MALT, 35 splenic and 20 nodal marginal zone lymphomas) and 13 lymphoplasmacytic lymphomas. Overall, 90% exhibited copy-number abnormalities. Lymphoplasmacytic lymphomas demonstrated the most complex karyotype (median=7 copy-number abnormalities), followed by MALT (4), nodal (3.5) and splenic marginal zone lymphomas (3). A comparative analysis exposed a group of copy-number abnormalities shared by several or all the entities with few disease-specific abnormalities. Gain of chromosomes 3, 12 and 18 and loss of 6q23-q24 (TNFAIP3) were identified in all entities. Losses of 13q14.3 (MIRN15A-MIRN16-1) and 17p13.3-p12 (TP53) were found in lymphoplasmacytic and splenic marginal zone lymphomas; loss of 11q21-q22 (ATM) was found in nodal, splenic marginal zone and lymphoplasmacytic lymphomas and loss of 7q32.1-q33 was found in MALT, splenic and lymphoplasmacytic lymphomas. Abnormalities affecting the nuclear factor kappa B pathway were observed in 70% of MALT and lymphoplasmacytic lymphomas and 30% of splenic and nodal marginal zone lymphomas, suggesting distinct roles of this pathway in the pathogenesis/progression of these subtypes. Elucidation of the genetic alterations contributing to the pathogenesis of these lymphomas may guide to design-specific therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)651-660
Number of pages10
JournalModern Pathology
Volume25
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Lymphoma
Marginal Zone B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Chromosomes, Human, Pair 18
Chromosomes, Human, Pair 12
Chromosomes, Human, Pair 3
Comparative Genomic Hybridization
NF-kappa B
Karyotype
Cell Differentiation

Keywords

  • aCGH
  • copy-number abnormalities
  • LPL
  • MZL
  • NF-κB pathway

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. / Braggio, Esteban D; Dogan, Ahmet; Keats, Jonathan J.; Chng, Wee J.; Huang, Gaofeng; Matthews, Julie M.; Maurer, Matthew J.; Law, Mark E.; Bosler, David S.; Barrett, Michael; Lossos, Izidore S.; Witzig, Thomas Elmer; Fonseca, Rafael.

In: Modern Pathology, Vol. 25, No. 5, 05.2012, p. 651-660.

Research output: Contribution to journalArticle

Braggio, Esteban D ; Dogan, Ahmet ; Keats, Jonathan J. ; Chng, Wee J. ; Huang, Gaofeng ; Matthews, Julie M. ; Maurer, Matthew J. ; Law, Mark E. ; Bosler, David S. ; Barrett, Michael ; Lossos, Izidore S. ; Witzig, Thomas Elmer ; Fonseca, Rafael. / Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. In: Modern Pathology. 2012 ; Vol. 25, No. 5. pp. 651-660.
@article{979eefd7961240f8ba70eeadae42747d,
title = "Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities",
abstract = "Lymphoplasmacytic lymphomas and marginal zone lymphomas of nodal, extra-nodal and splenic types account for 10{\%} of non-Hodgkin lymphomas. They are similar at the cell differentiation level, sometimes making difficult to distinguish them from other indolent non-Hodgkin lymphomas. To better characterize their genetic basis, we performed array-based comparative genomic hybridization in 101 marginal zone lymphomas (46 MALT, 35 splenic and 20 nodal marginal zone lymphomas) and 13 lymphoplasmacytic lymphomas. Overall, 90{\%} exhibited copy-number abnormalities. Lymphoplasmacytic lymphomas demonstrated the most complex karyotype (median=7 copy-number abnormalities), followed by MALT (4), nodal (3.5) and splenic marginal zone lymphomas (3). A comparative analysis exposed a group of copy-number abnormalities shared by several or all the entities with few disease-specific abnormalities. Gain of chromosomes 3, 12 and 18 and loss of 6q23-q24 (TNFAIP3) were identified in all entities. Losses of 13q14.3 (MIRN15A-MIRN16-1) and 17p13.3-p12 (TP53) were found in lymphoplasmacytic and splenic marginal zone lymphomas; loss of 11q21-q22 (ATM) was found in nodal, splenic marginal zone and lymphoplasmacytic lymphomas and loss of 7q32.1-q33 was found in MALT, splenic and lymphoplasmacytic lymphomas. Abnormalities affecting the nuclear factor kappa B pathway were observed in 70{\%} of MALT and lymphoplasmacytic lymphomas and 30{\%} of splenic and nodal marginal zone lymphomas, suggesting distinct roles of this pathway in the pathogenesis/progression of these subtypes. Elucidation of the genetic alterations contributing to the pathogenesis of these lymphomas may guide to design-specific therapeutic approaches.",
keywords = "aCGH, copy-number abnormalities, LPL, MZL, NF-κB pathway",
author = "Braggio, {Esteban D} and Ahmet Dogan and Keats, {Jonathan J.} and Chng, {Wee J.} and Gaofeng Huang and Matthews, {Julie M.} and Maurer, {Matthew J.} and Law, {Mark E.} and Bosler, {David S.} and Michael Barrett and Lossos, {Izidore S.} and Witzig, {Thomas Elmer} and Rafael Fonseca",
year = "2012",
month = "5",
doi = "10.1038/modpathol.2011.213",
language = "English (US)",
volume = "25",
pages = "651--660",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

AU - Braggio, Esteban D

AU - Dogan, Ahmet

AU - Keats, Jonathan J.

AU - Chng, Wee J.

AU - Huang, Gaofeng

AU - Matthews, Julie M.

AU - Maurer, Matthew J.

AU - Law, Mark E.

AU - Bosler, David S.

AU - Barrett, Michael

AU - Lossos, Izidore S.

AU - Witzig, Thomas Elmer

AU - Fonseca, Rafael

PY - 2012/5

Y1 - 2012/5

N2 - Lymphoplasmacytic lymphomas and marginal zone lymphomas of nodal, extra-nodal and splenic types account for 10% of non-Hodgkin lymphomas. They are similar at the cell differentiation level, sometimes making difficult to distinguish them from other indolent non-Hodgkin lymphomas. To better characterize their genetic basis, we performed array-based comparative genomic hybridization in 101 marginal zone lymphomas (46 MALT, 35 splenic and 20 nodal marginal zone lymphomas) and 13 lymphoplasmacytic lymphomas. Overall, 90% exhibited copy-number abnormalities. Lymphoplasmacytic lymphomas demonstrated the most complex karyotype (median=7 copy-number abnormalities), followed by MALT (4), nodal (3.5) and splenic marginal zone lymphomas (3). A comparative analysis exposed a group of copy-number abnormalities shared by several or all the entities with few disease-specific abnormalities. Gain of chromosomes 3, 12 and 18 and loss of 6q23-q24 (TNFAIP3) were identified in all entities. Losses of 13q14.3 (MIRN15A-MIRN16-1) and 17p13.3-p12 (TP53) were found in lymphoplasmacytic and splenic marginal zone lymphomas; loss of 11q21-q22 (ATM) was found in nodal, splenic marginal zone and lymphoplasmacytic lymphomas and loss of 7q32.1-q33 was found in MALT, splenic and lymphoplasmacytic lymphomas. Abnormalities affecting the nuclear factor kappa B pathway were observed in 70% of MALT and lymphoplasmacytic lymphomas and 30% of splenic and nodal marginal zone lymphomas, suggesting distinct roles of this pathway in the pathogenesis/progression of these subtypes. Elucidation of the genetic alterations contributing to the pathogenesis of these lymphomas may guide to design-specific therapeutic approaches.

AB - Lymphoplasmacytic lymphomas and marginal zone lymphomas of nodal, extra-nodal and splenic types account for 10% of non-Hodgkin lymphomas. They are similar at the cell differentiation level, sometimes making difficult to distinguish them from other indolent non-Hodgkin lymphomas. To better characterize their genetic basis, we performed array-based comparative genomic hybridization in 101 marginal zone lymphomas (46 MALT, 35 splenic and 20 nodal marginal zone lymphomas) and 13 lymphoplasmacytic lymphomas. Overall, 90% exhibited copy-number abnormalities. Lymphoplasmacytic lymphomas demonstrated the most complex karyotype (median=7 copy-number abnormalities), followed by MALT (4), nodal (3.5) and splenic marginal zone lymphomas (3). A comparative analysis exposed a group of copy-number abnormalities shared by several or all the entities with few disease-specific abnormalities. Gain of chromosomes 3, 12 and 18 and loss of 6q23-q24 (TNFAIP3) were identified in all entities. Losses of 13q14.3 (MIRN15A-MIRN16-1) and 17p13.3-p12 (TP53) were found in lymphoplasmacytic and splenic marginal zone lymphomas; loss of 11q21-q22 (ATM) was found in nodal, splenic marginal zone and lymphoplasmacytic lymphomas and loss of 7q32.1-q33 was found in MALT, splenic and lymphoplasmacytic lymphomas. Abnormalities affecting the nuclear factor kappa B pathway were observed in 70% of MALT and lymphoplasmacytic lymphomas and 30% of splenic and nodal marginal zone lymphomas, suggesting distinct roles of this pathway in the pathogenesis/progression of these subtypes. Elucidation of the genetic alterations contributing to the pathogenesis of these lymphomas may guide to design-specific therapeutic approaches.

KW - aCGH

KW - copy-number abnormalities

KW - LPL

KW - MZL

KW - NF-κB pathway

UR - http://www.scopus.com/inward/record.url?scp=84860465703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860465703&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2011.213

DO - 10.1038/modpathol.2011.213

M3 - Article

C2 - 22301699

AN - SCOPUS:84860465703

VL - 25

SP - 651

EP - 660

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -